Article - 01/06/2017 Biotechnology – key technology of the 21st century According to a study published by the German National Academy of Science and Engineering (acatech) on 5th April, biotechnology is a key technology of the 21st century and has huge innovation potential. What are the trends within the industry and what are the challenges we face?https://www.gesundheitsindustrie-bw.de/en/article/news/biotechnology-key-technology-of-the-21st-century
High-tech - 20/10/2016 Industry 4.0 in the medical technology and pharmaceutical industry sectors The digitalisation of industry affects the entire value chain. From individual products to digitising workflows in companies and connecting companies with clients and service providers via the Internet of Things – Industry 4.0 makes completely new manufacturing processes possible and requires new and specific business models. https://www.gesundheitsindustrie-bw.de/en/article/dossier/industry-40-in-the-medical-technology-and-pharmaceutical-industry-sectors
Article - 10/10/2016 Teva plans the large-scale production of monoclonal antibodies in Ulm Teva is investing heavily in its biotechnological production site in Ulm. On behalf of BIOPRO Baden-Württemberg, Walter Pytlik spoke with Dr. Hermann Allgaier, CEO of Teva Biotech, about the importance of biotechnology for the Group and about Teva in general. The company is headquartered in Israel.https://www.gesundheitsindustrie-bw.de/en/article/news/teva-plans-the-large-scale-production-of-monoclonal-antibodies-in-ulm
Press release - 16/11/2015 The Baden-Württemberg healthcare industry – a strong economic power (Stuttgart – 16th November 2015) BIOPRO Baden-Württemberg has just published its latest analysis of the Baden-Württemberg healthcare industry including comprehensive facts and figures. Baden-Württemberg continues to be one of the top locations for medical technology, pharma and biotechnology in Germany. https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-baden-wuerttemberg-healthcare-industry-a-strong-economic-power
Article - 10/05/2010 CeGaT: DNA and RNA sequencing specialist Sequencing service providers are facing new challenges due to the enormous technological progress made in this field. The market requires technically feasible solutions reliable and rapid sequence analyses in which entire genomes can be analysed within a couple of days or weeks. This can only be achieved with state-of-the-art high-throughput technologies. Tübingen-based CeGaT GmbH has been offering DNA and RNA sequencing using state-of-the-art…https://www.gesundheitsindustrie-bw.de/en/article/news/cegat-dna-and-rna-sequencing-specialist
Article - 15/05/2009 Interdisciplinarity starts with support and supervision As new General Manager the all-round talent Dr. Heike Brandstädter has taken the helm of the PhD Graduate School. Through her work at the crossroads of the humanities and natural sciences her particular aim is to lessen the burden on young researchers and increase their chances of success on the job market.https://www.gesundheitsindustrie-bw.de/en/article/news/interdisciplinarity-starts-with-support-and-supervision
Article - 14/07/2008 Basis for 21st Century Medicine Dr. Annette Schavan the Federal Minister of Education and Research visited the famous university town of Tübingen to gain a first-hand impression of the bioregions vast potentials in the fields of biotechnology and medical technology.https://www.gesundheitsindustrie-bw.de/en/article/news/basis-for-21st-century-medicine
Article - 17/06/2008 "Study and work abroad!”" Quick practically oriented and above all international The new bachelor and masters degrees in the natural sciences have been introduced to bring German university qualifications into line with the requirements of the international job market as well as to facilitate the uncomplicated exchange of scientists across the globe. However not everything always works out as planned. Research abroad is often limited by time and money.https://www.gesundheitsindustrie-bw.de/en/article/news/study-and-work-abroad